Advertisement

Atopic Dermatitis and Celiac Disease: A Cross-Sectional Study of 116,816 Patients

  • Guy Shalom
  • Khalaf KridinEmail author
  • Keren-Or Raviv
  • Tamar Freud
  • Doron Comaneshter
  • Rivka Friedland
  • Arnon D. Cohen
  • Dan Ben-Amitai
Original Research Article

Abstract

Background

Both atopic dermatitis and celiac disease are often accompanied by other immune-mediated disorders.

Objective

The objective of this study was to evaluate the potential association between atopic dermatitis and celiac disease in a broad community-based population.

Methods

A cross-sectional observational design was used. Demographic and clinical data were collected for patients enrolled in a large health management organization who were diagnosed with atopic dermatitis by a dermatologist in 2002–17. The presence of celiac disease/celiac disease-related morbidities was recorded for the whole group, for adults (age > 18 years), and for adults with moderate-to-severe atopic dermatitis. Findings were compared with a matched control group without atopic dermatitis.

Results

The study group included 116,816 patients of whom 45,157 were adults; 1909 adult patients had moderate-to-severe atopic dermatitis. Compared to the respective control subjects, the prevalence rate of celiac disease in the whole group was 0.6% vs. 0.4%; in the adults, 0.6% vs. 0.3%; and in the adults with moderate-to-severe atopic dermatitis, 0.8% vs. 0.3% (p < 0.001 for all). On multivariate analysis, atopic dermatitis was associated with a significantly higher prevalence of celiac disease (odds ratio = 1.609, 95% confidence interval 1.42–1.82, p < 0.001) in the entire study population and each subgroup.

Conclusions

We observed a significant association between atopic dermatitis and celiac disease. This association emphasizes the need for timely screening of gastrointestinal morbidities in individuals with atopic dermatitis to prevent long-term complications.

Notes

Compliance with Ethical Standards

Funding

No funding was received for the conduct of this study or the preparation of this article.

Conflict of interest

Guy Shalom, Khalaf Kridin, Keren-Or Raviv, Tamar Freud, Doron Comaneshter, Rivka Friedland, Arnon D. Cohen, and Dan Ben-Amitai have no conflicts of interest that are directly relevant to the content of this article.

Ethical approval

The present study was conducted in accordance with the Declaration of Helsinki and all appropriate amendments. The study was approved by the Ethics Review Committee of Clalit Health Services.

References

  1. 1.
    Nutten S. Atopic dermatitis: global epidemiology and risk factors. Ann Nutr Metabl. 2015;66(Suppl. 1):8–16.CrossRefGoogle Scholar
  2. 2.
    Asher MI, Montefort S, Björkstén B, et al.; ISAAC Phase Three Study Group. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet. 2006;368:733–43.Google Scholar
  3. 3.
    Dharmage SC, Lowe AJ, Matheson MC, Burgess JA, Allen KJ, Abramson MJ. Atopic dermatitis and the atopic march revisited. Allergy Eur J Allergy Clin Immunol. 2014;69:17–27.CrossRefGoogle Scholar
  4. 4.
    Shaker M. New insights into the allergic march. Curr Opin Pediatr. 2014;26:516–20.CrossRefGoogle Scholar
  5. 5.
    Spergel JM. From atopic dermatitis to asthma: the atopic march. Ann Allergy Asthma Immunol. 2010;105:99–106 (quiz 107–9, 117).CrossRefGoogle Scholar
  6. 6.
    Sidbury R, Davis DM, Cohen DE, et al.; American Academy of Dermatology. Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents. J Am Acad Dermatol. 2014;71:327–49.Google Scholar
  7. 7.
    Rabin RL, Levinson AI. The nexus between atopic disease and autoimmunity: a review of the epidemiological and mechanistic literature. Clin Exp Immunol. 2008;153:19–30.CrossRefGoogle Scholar
  8. 8.
    Simpson CR, Anderson WJA, Helms PJ, et al. Coincidence of immune-mediated diseases driven by TH1 and TH2 subsets suggests a common aetiology: a population-based study using computerized general practice data. Clin Exp Allergy. 2002;32:37–42.CrossRefGoogle Scholar
  9. 9.
    Tang TS, Bieber T, Williams HC. Does “autoreactivity” play a role in atopic dermatitis? J Allergy Clin Immunol. 2012;129(1209–15):e2.Google Scholar
  10. 10.
    Rodrigo L, Beteta-Gorriti V, Alvarez N, et al. Cutaneous and mucosal manifestations associated with celiac disease. Nutrients. 2018;10. (pii:E800).Google Scholar
  11. 11.
    Elli L, Bonura A, Garavaglia D, et al. Immunological comorbity in coeliac disease: associations, risk factors and clinical implications. J Clin Immunol. 2012;32:984–90.CrossRefGoogle Scholar
  12. 12.
    Ress K, Annus T, Putnik U, Luts K, Uibo R, Uibo O. Celiac disease in children with atopic dermatitis. Pediatr Dermatol. 2014;31:483–8.CrossRefGoogle Scholar
  13. 13.
    Ciacci C, Cavallaro R, Iovino P, et al. Allergy prevalence in adult celiac disease. J Allergy Clin Immunol. 2004;113:1199–203.CrossRefGoogle Scholar
  14. 14.
    Verkasalo M, Tiilikainen A, Kuitunen P, Savilahti E, Backman A. HLA antigens and atopy in children with coeliac disease. Gut. 1983;24:306–10.CrossRefGoogle Scholar
  15. 15.
    Rennert G, Peterburg Y. Prevalence of selected chronic diseases in Israel. Isr Med Assoc J. 2001;3:404–8.PubMedGoogle Scholar
  16. 16.
    Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.CrossRefGoogle Scholar
  17. 17.
    Zauli D, Grassi A, Granito A, et al. Prevalence of silent coeliac disease in atopics. Dig Liver Dis. 2000;32:775–9.CrossRefGoogle Scholar
  18. 18.
    Cooper BT, Holmes GK, Cooke WT. Coeliac disease and immunological disorders. Br Med J. 1978;1:537–9.CrossRefGoogle Scholar
  19. 19.
    Mazzarella G. Effector and suppressor T cells in celiac disease. World J Gastroenterol. 2015;21:7349–56.CrossRefGoogle Scholar
  20. 20.
    Del Prete G. Human Th1 and Th2 lymphocytes: their role in the pathophysiology of atopy. Allergy. 1992;47:450–5.CrossRefGoogle Scholar
  21. 21.
    Bischoff SC, Mayer JH, Manns MP. Allergy and the gut. Int Arch Allergy Immunol. 2000;121:270–83.CrossRefGoogle Scholar
  22. 22.
    Cipriani F, Marzatico A, Ricci G. Autoimmune diseases involving skin and intestinal mucosa are more frequent in adolescents and young adults suffering from atopic dermatitis. J Dermatol. 2017;44:1341–8.CrossRefGoogle Scholar
  23. 23.
    Jones G, Wu S, Jang N, Fulcher D, Hogan P, Stewart G. Polymorphisms within the CTLA4 gene are associated with infant atopic dermatitis. Br J Dermatol. 2006;154:467–71.CrossRefGoogle Scholar
  24. 24.
    King AL, Moodie SJ, Fraser JS, et al. Coeliac disease: investigation of proposed causal variants in the CTLA4 gene region. Eur J Immunogenet. 2003;30:427–32.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Clalit Health ServicesTel AvivIsrael
  2. 2.Division of Community Health, Faculty of Health Sciences, Siaal Research Center for Family Medicine and Primary CareBen Gurion University of the NegevBeer-ShevaIsrael
  3. 3.Department of DermatologyRambam Health Care CampusHaifaIsrael
  4. 4.Pediatric Dermatology UnitSchneider Children’s Medical Center of IsraelPetach TikvaIsrael
  5. 5.Chief Physician’s Office, Clalit Health ServicesTel AvivIsrael
  6. 6.Sackler Faculty of MedicineTel Aviv UniversityTel AvivIsrael

Personalised recommendations